BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10959099)

  • 21. Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22.
    Aventín A; La Starza R; Nomdedéu J; Brunet S; Sierra J; Mecucci C
    Cancer Genet Cytogenet; 2000 Dec; 123(2):137-9. PubMed ID: 11150605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.
    Marlton P; Claxton DF; Liu P; Estey EH; Beran M; LeBeau M; Testa JR; Collins FS; Rowley JD; Siciliano MJ
    Blood; 1995 Feb; 85(3):772-9. PubMed ID: 7833479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular identification of CBFbeta-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses--a rare occurrence.
    Ravandi F; Kadkol SS; Ridgeway J; Bruno A; Dodge C; Lindgren V
    Leukemia; 2003 Sep; 17(9):1907-10. PubMed ID: 12970795
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
    Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
    Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).
    Dai HP; Xue YQ; Wu LL; Pan JL; Gong YL; Wu YF; Zhang J; Wu DP; Chen SN
    Int J Hematol; 2012 Dec; 96(6):814-7. PubMed ID: 23054652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
    Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 16 inversion-associated translocations in acute myeloid leukemia elucidated using a dual-color CBFB DNA probe.
    Aventín A; Espadaler M; Casas S; Duarte J; Nomdedéu J; Sierra J
    Cancer Genet Cytogenet; 2002 Apr; 134(2):142-4. PubMed ID: 12034528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
    Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
    Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics.
    Costello R; Sainty D; Lecine P; Cusenier A; Mozziconacci MJ; Arnoulet C; Maraninchi D; Gastaut JA; Imbert J; Lafage-Pochitaloff M; Gabert J
    Leukemia; 1997 May; 11(5):644-50. PubMed ID: 9180286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CBFB/MYH11 fusion transcripts in a case of acute myelogenous leukemia (M1) with partial deletion of the long arm of chromosome 16.
    Usuki K; Nakatsu M; Kitazume K; Endo M; Osawa M; Iki S; Arai M; Urabe A
    Intern Med; 1996 Apr; 35(4):327-30. PubMed ID: 8739792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
    Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
    Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
    Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
    J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is inversion 16 a prerequisite and id trisomy 22 invariably associated with inversion 16 in AML-M4eo?
    Litmanovich D; Zamir-Brill R; Jeison M; Gershoni-Baruch R
    Cancer Genet Cytogenet; 2000 Aug; 121(1):106. PubMed ID: 10991620
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of inv (16) in acute myelomonocytic leukemia by interphase fluorescence in situ hybridization].
    Li J; Pan J; Wu Y; Guo Y; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):30-2. PubMed ID: 12015086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
    Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
    Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
    Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
    Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
    Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
    Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
    Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
    Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
    Grardel N; Roumier C; Soenen V; Lai JL; Plantier I; Gheveart C; Cosson A; Fenaux P; Preudhomme C
    Leukemia; 2002 Jan; 16(1):150-1. PubMed ID: 11840275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.